Women with endometriosis may soon have a quicker path to diagnosis, cutting down on the lengthy wait times currently endured. The National Institute for Health and Care Excellence (NICE) has endorsed two new non-invasive tests that could significantly reduce the average diagnosis time, which currently exceeds nine years.
This painful condition, affecting about one in 10 women of reproductive age in the UK, involves the growth of womb-like cells in other areas of the body. Symptoms include intense pelvic pain, heavy menstrual periods, fatigue, and infertility. The approved tests, EndoSure and Endotest, will be available within the NHS for three years while their effectiveness is further evaluated. Although not all GP practices will have immediate access, patients without direct access should be supervised by a healthcare professional experienced in endometriosis diagnosis.
Endotest utilizes a saliva sample to detect microRNAs associated with endometriosis, while EndoSure measures gut electrical signals using sensor pads on the abdomen. While these tests do not provide a definitive diagnosis on their own, they are expected to assist in identifying patients requiring further evaluation and treatment promptly.
These developments follow a survey by the All-Party Parliamentary Group on Endometriosis, revealing that more than half of the surveyed women had visited their GP over 10 times before diagnosis, with many also seeking medical attention in A&E due to symptoms. Dr. Anastasia Chalkidou from NICE emphasized the potential of these technologies in expediting endometriosis identification and treatment, aiming to ease the burden of chronic pelvic pain and improve patients’ quality of life.
Simran Chavda, a 15-year-old from Huddersfield, found relief after years of searching for answers to her pelvic pain. Her positive experience with the gut test highlights the simplicity and effectiveness of the new diagnostic tools, bringing hope for earlier intervention and symptom management. Dr. Gail Busby, a consultant gynaecologist, emphasized the transformative impact of early endometriosis diagnosis not only on individual lives but also on overall healthcare resource allocation and accessibility.
